ArticlePloS one2026
Minimal mutational requirements for conversion of a telomere resolvase into a Cre-like site-specific recombinase.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hairpin telomere resolvases comprise a family of enzymes that produce the hairpin (hp) telomeres of bacteria and their phages that possess linear chromosomes and plasmids terminated by covalently closed hp telomeres. The hp telomeres overcome the dual issues of end replication and protection faced by all organisms with linear genomes. The hp telomeres are produced from replicated intermediates in which the hp telomeres have been converted into replicated telomere (rTel) junctions possessing inverted repeat symmetry. The telomere resolvases process the rTel junctions in a reaction with mechanistic similarities to that promoted by type IB topoisomerases and tyrosine recombinases. The telomere resolvase of both Borrelia burgdorferi (ResT) and Agrobacterium tumefaciens (TelA) have been shown to be able to promote, under certain conditions, a Cre-like recombination between rTel junctions to produce the Holliday junction (HJ) intermediate typical of recombination reactions promoted by tyrosine recombinases. For TelA mutation of the enzyme was required to unmask this normally cryptic activity. A complex combination of autoinhibition domain deletion and point mutation of TelA had even been shown to completely switch the activity of TelA from a telomere resolvase to a recombinase. We report here that mutation of a pair of aspartic acid residues in TelA is sufficient to accomplish this switch in activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.